PAR 1.89% 26.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-1607

  1. 4,132 Posts.
    lightbulb Created with Sketch. 6609
    Short answer to that is the Bene are today very capable of ramping up production significantly. They have at least 2 manufacturing plants that are only running one shift out of a max of two or three. Increased capacity is easily achievable. They will have plenty of time and notice to increase to meet supply is what I am hearing from multiple sources. They can manufacture not in Kilos but in Tonnes.

    It's possibly currently limited to give preference to trials in Europe and US along with some Australian numbers in both MPS and OA streams. When they need it they will expand and have the ability to do so.

    DYOR

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
26.0¢
Change
-0.005(1.89%)
Mkt cap ! $90.94M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $68.12K 259.5K

Buyers (Bids)

No. Vol. Price($)
3 94536 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 83592 4
View Market Depth
Last trade - 16.10pm 28/05/2024 (20 minute delay) ?
Last
26.5¢
  Change
-0.005 ( 1.92 %)
Open High Low Volume
26.0¢ 27.0¢ 25.8¢ 197521
Last updated 15.59pm 28/05/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.